MAPK14 and Alzheimer disease: Furthermore, acacetin enhanced the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which activates the classical Ras/MAPK pathway, to induce neuritogenesis and neuronal differentiation73; therefore, acacetin is a potential therapeutic agent for AD.